 | | | | |
| |  | |  | | |
| |
 |
| PRIME NEWS | |
|
 |
|
|
3SBio,a biotechnology company focused on manufacturing biopharma products and Isotechnika, a biopharma company focused on the discovery and development of immune modulating therapeutics, have signed of a development agreement for voclosporin
|
|
|
|
|
|
|
|
|
Cellonis Biotechnologies, a Beijing-based medical research company, has recorded some remarkable results in the treatment of a twelve-year-old boy with diabetes using their stem cell therapy in a Beijing hospital.
|
|
|
|
|
|
|
| | | 
BioSpectrum China provides complete information on China medical technologies articles. It covers areas of China pharmaceutical industry, Chinese herbal medicine and China medical equipment.
| | | | |  | |  | | |
|
|
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
|
|
|
TCM at $1.46 bn in global market
|
|
| Exports of traditional Chinese medicine (TCM) in the global market were valued at $1.46 billion in 2009, according to Wang Guoqiang, Director of the State Administration of TCM. |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
FEATURES |
|
|
|
|
China, India look for domestic consolidation
|
|
| Large multinational pharma companies continue to be active in seeking acquisitions in emerging Asian markets such as India and China. With over $70 bn drugs coming off patent by 2012, pharma majors are looking to these regions for new revenue streams |
|
|
|
|
|
Pharma Prospects: A billion reasons to invest in China
|
|
| Over the next three years, Chinas GDP is expected to grow between seven and nine percent per annum. The overall compound annual growth rate of the pharmaceutical market (2009-13), is projected to be 24 percent, with the market reaching an estimated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
Renhuang appoints interim CFO
|
|
| Renhuang Pharmaceuticals has appointed Ms Xiaoying Lu as its Interim Chief Financial Officer, while the company seeks a permanent replacement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
|
|
Biopharma leaders to meet at BioManufacturing World
|
|
| On October 18-21, 2010, the heads of global technical operations and heads of manufacturing from major biopharmaceutical players are meeting in Shanghai at BioManufacturing World and Vaccine Manufacturing World conferences, hosted by IMAPAC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
|
|
Rank 4: Shenzhen, a production-to-retail pharma company
|
|
| The BioSpectrum Asia Pacific Survey 2010 gives a rounded view of the progress the life sciences industry has made. Shenzhen Accord distributes its products in domestic and overseas markets. The company has four subsidiaries and one associate. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
